A detailed history of Vanguard Group Inc transactions in Femasys Inc stock. As of the latest transaction made, Vanguard Group Inc holds 192,667 shares of FEMY stock, worth $219,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares
192,667
Previous 192,667 -0.0%
Holding current value
$219,640
Previous $298,000 26.51%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$0.75 - $2.22 $28,054 - $83,041
37,406 Added 24.09%
192,667 $298,000
Q4 2023

Feb 14, 2024

BUY
$0.76 - $3.89 $51,404 - $263,111
67,638 Added 77.19%
155,261 $152,000
Q3 2023

Nov 14, 2023

SELL
$0.31 - $2.98 $15,348 - $147,539
-49,510 Reduced 36.1%
87,623 $261,000
Q3 2022

Nov 14, 2022

BUY
$1.13 - $2.54 $20,281 - $45,587
17,948 Added 15.06%
137,133 $155,000
Q1 2022

May 13, 2022

BUY
$1.76 - $3.99 $209,765 - $475,548
119,185 New
119,185 $269,000

Others Institutions Holding FEMY

About FEMASYS INC


  • Ticker FEMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 11,813,600
  • Market Cap $13.5M
  • Description
  • Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support...
More about FEMY
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.